Antheia, a pharmaceutical ingredient manufacturer, and Olon Group, a developer and manufacturer of active pharmaceutical ingredients (APIs) for CDMO and generic markets, announced an ongoing partnership to leverage Olon’s vast fermentation infrastructure to manufacture Antheia’s early products.   Antheia and Olon partnered in 2022 to leverage Olon’s fermentation sites across Italy. Olon has since served as a CDMO for scaling Antheia’s biomanufacturing processes and producing its Biosynthetic K...